Role of ultrastructural determinants of glomerular permeability in ultrafiltration function loss.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
09 07 2020
Historique:
received: 12 02 2020
accepted: 27 05 2020
entrez: 10 7 2020
pubmed: 10 7 2020
medline: 10 6 2021
Statut: epublish

Résumé

The epithelial filtration slit is a crucial component of the glomerular capillary membrane, which is essential for maintaining glomerular filtration function. Though chronic kidney diseases are an immense clinical problem, the mechanisms through which structural alterations reduce glomerular water filtration have not yet been understood completely. To investigate the mechanisms underlying filtration function loss, we studied rats with spontaneously occurring progressive kidney disease, either treated with angiotensin II antagonist or untreated, combining high-resolution electron microscopy of the glomerular capillary wall with theoretical water filtration modeling. Under pathological conditions, epithelial filtration pores and the extension of the subpodocyte space were larger than in normal controls. Numerical analyses indicated that these ultrastructural changes increased hydraulic resistance of the glomerular capillary wall by extending coverage of the filtration barrier by the subpodocyte space, with the changes in hydrodynamic forces acting on podocytes likely being responsible for their detachment. Angiotensin II inhibition normalized the subpodocyte space's hydraulic resistance, restored mechanical podocyte load, and preserved CD151-α3 integrin complex assembly, improving podocyte adherence and survival. Our results show that ultrastructural changes in podocytes are major determinants of the hydraulic resistance of the glomerular capillary wall and highlight the mechanism of podocyte loss in kidney disease progression, as well as the mechanisms underlying angiotensin II inhibition.

Identifiants

pubmed: 32641585
pii: 137249
doi: 10.1172/jci.insight.137249
pmc: PMC7406295
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Drug Discov Today Dis Models. 2010;7(1-2):13-19
pubmed: 21286234
Dev Biol. 2008 Apr 15;316(2):288-301
pubmed: 18328474
J Lab Clin Med. 2006 Feb;147(2):74-82
pubmed: 16459165
J Am Soc Nephrol. 2005 May;16(5):1223-35
pubmed: 15829713
Nephrology (Carlton). 2006 Aug;11(4):274-81
pubmed: 16889564
Am J Pathol. 2009 Mar;174(3):797-807
pubmed: 19164508
J Am Soc Nephrol. 2015 Feb;26(2):258-69
pubmed: 25060060
J Am Soc Nephrol. 1998 Aug;9(8):1399-406
pubmed: 9697661
J Am Soc Nephrol. 2010 Dec;21(12):2081-9
pubmed: 21030599
J Microsc. 2006 Dec;224(Pt 3):213-32
pubmed: 17210054
Blood. 2004 Oct 15;104(8):2217-23
pubmed: 15265795
Am J Physiol Renal Physiol. 2007 Dec;293(6):F1777-86
pubmed: 17804486
Am J Physiol Renal Physiol. 2007 Dec;293(6):F1787-98
pubmed: 17715264
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
J Cell Biol. 2006 Oct 9;175(1):33-9
pubmed: 17015618
J Cell Biol. 2003 Dec 22;163(6):1351-62
pubmed: 14691142
Sci Rep. 2017 Aug 16;7(1):8321
pubmed: 28814739
J Clin Invest. 2012 Jan;122(1):348-58
pubmed: 22201679
Am J Physiol. 1994 Jan;266(1 Pt 2):F1-12
pubmed: 8304474
Physiology (Bethesda). 2005 Aug;20:218-24
pubmed: 16024509
Semin Nephrol. 2004 Mar;24(2):131-40
pubmed: 15017525
J Clin Invest. 1975 Feb;55(2):305-18
pubmed: 1127101
Curr Opin Nephrol Hypertens. 2001 Jul;10(4):543-9
pubmed: 11458036
Front Endocrinol (Lausanne). 2014 Oct 14;5:160
pubmed: 25352829
Kidney Int. 1988 Oct;34(4):481-6
pubmed: 3199667
Am J Physiol Renal Physiol. 2012 May 15;302(10):F1265-77
pubmed: 22338088
Am J Pathol. 2006 Jan;168(1):42-54
pubmed: 16400008
J Am Soc Nephrol. 2000 Mar;11(3):477-89
pubmed: 10703671
Am J Physiol Renal Physiol. 2001 Oct;281(4):F579-96
pubmed: 11553505
N Engl J Med. 2012 Apr 19;366(16):1508-14
pubmed: 22512483
Am J Kidney Dis. 1999 Oct;34(4):626-32
pubmed: 10516341
J Clin Invest. 1990 Feb;85(2):541-9
pubmed: 1688888
J Clin Invest. 2006 Feb;116(2):288-96
pubmed: 16453013
J Cell Biol. 1974 Feb;60(2):423-33
pubmed: 4204974
J Am Soc Nephrol. 1994 Dec;5(6):1378-84
pubmed: 7894005
PLoS One. 2013;8(3):e57051
pubmed: 23505418
Lab Invest. 1992 Nov;67(5):572-9
pubmed: 1434536
J Cell Sci. 1992 Nov;103 ( Pt 3):857-62
pubmed: 1478975
Microsc Res Tech. 2002 May 15;57(4):247-53
pubmed: 12012393
Am J Pathol. 2008 Oct;173(4):927-37
pubmed: 18787104

Auteurs

Andrea Remuzzi (A)

University of Bergamo, Dalmine, Italy.

Sara Conti (S)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

Bogdan Ene-Iordache (B)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

Susanna Tomasoni (S)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

Paola Rizzo (P)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

Ariela Benigni (A)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.

Giuseppe Remuzzi (G)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy.
L. Sacco Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH